Lodapolimab (anti-PD-L1) is an IgGλ anti-PD-1 monoclonal antibody.
Purity≥95% (SDS-PAGE&SEC)
Endotoxin Level ≤ 0.01EU/μg
Product Properties
Isotype
Human IgG1
Light Chain Type
lambda
SDS-PAGE
145 kDa
Purification Method
Protein A purified
Form
Liquid
Concentration
Lot by Lot
Storage Temp
Store at -80°C,Avoid repeated freezing and thawing
Shipped In
Ice chest + Ice pads
Stability And Storage
Store at -80℃ for 24 months. Upon delivery aliquot. Avoid freeze/thaw cycle.
CAS
2118349-31-6
Images
Lodapolimab (anti-PD-L1) (Ab182828) - Flow Cytometry Flow Cytometry analysis of MDA-MB-231 cells labelling PD-L1 (red) with Lodapolimab (anti-PD-L1) (Ab182828) at 1.0 μg/mL for 1 hour at 4°C. Goat Anti-Human IgG (PE) (Ab175838) at a dilution of 1/1000 was used as the secondary antibody. Blue - Isotype control, human IgG (Ab170213). Black - Unlabelled control, cells without incubation with primary antibody.
Lodapolimab (anti-PD-L1) (Ab182828) - ELISA Immobilized Recombinant Human PD-L1 protein (rp169666) at 1.0 μg/mL can bind Lodapolimab (anti-PD-L1) (Ab182828) with the EC
₅₀
of 98.19 ng/mL.
Lodapolimab (anti-PD-L1) (Ab182828) - SEC The purity of Lodapolimab (anti-PD-L1) (Ab182828) is more than 95% verified by HPLC.
Associated Targets
CD274Tclin Programmed cell death 1 ligand 1 0 Activities